✦ LIBER ✦

Effect of anastrozole on bone mineral density and bone fractures: results from the ‘Arimidex’ (anastrozole), Tamoxifen, alone or in combination (ATAC) trial

✍ Scribed by R Coleman

Book ID: 118622240
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 156 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)90892-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anastrozole has a protective effect on t

Anastrozole has a protective effect on the endometrium: data from the ATAC (‘Arimidex’, Tamoxifen, alone or in combination) trial

✍ S Duffy; M Greenwood 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Fewer endometrial abnormalities with ana

Fewer endometrial abnormalities with anastrozole than tamoxifen: Endometrial subprotocol results from the ATAC ('Arimidex', Tamoxifen, Alone or in Combination) early breast cancer trial in postmenopausal patients

✍ Sean Duffy 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Impact of chemotherapy regimens prior to

Impact of chemotherapy regimens prior to endocrine therapy : Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial

✍ Aman U. Buzdar; Jean-Paul Guastalla; Jean-Marc Nabholtz; Jack Cuzick; on behalf 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

Anastrozole alone or in combination with

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer : Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

✍ The ATAC (Arimidex; Tamoxifen Alone or in Combination) Trialists' Group 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract ## BACKGROUND The first analysis of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial (median follow‐up, 33 months) demonstrated that in adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer, anastrozole was superior to tamoxifen in terms of d

A 7-month (MTH) safety update from the A

A 7-month (MTH) safety update from the ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) trial: Anastrozole (A) maintains a beneficial side-effect profile compared with tamoxifen (T)

✍ Anthony Howell 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 270 KB

0130 Initial adjuvant therapy with anast

0130 Initial adjuvant therapy with anastrozole - early- and late-event data from the arimidex, tamoxifen, alone or in combination (ATAC) trial in the hormone-responsive population

✍ A. Howell; J. Forbes; J. Cuzick 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB